Optimization of Substituted 6-Salicyl-4-Anilinoquinazoline Derivatives as Dual EGFR/HER2 Tyrosine Kinase Inhibitors

por Li, Dong-Dong, Qin, Ya-Juan, Sun, Jian, Li, Jing-Ran, Fang, Fei, Du, Qian-Ru, Qian, Yong, Gong, Hai-Bin, Zhu, Hai-Liang
Publicado 2013